1.Histone Deacetylase Inhibitors ---Promising Agents for \lqGene-Regulating Chemoprevention\rq and \lqMolecular-Targeting Prevention\rq of Cancer---
Youichirou MATSUZAKI ; Yoshihiro SOWA ; Tohru HIROSE ; Tomoya YOKOTA ; Toshiyuki SAKAI
Environmental Health and Preventive Medicine 2003;8(5,6):157-160
One of the best approaches against cancer is prevention. Inactivation of the p53 or p16INK4a genes has been extensively reported in most human cancer cells. Both p53 and p16INK4a function as tumor suppressors. Therefore, functional restoration of these molecules is considered to be one of the most useful methods for cancer prevention and therapy. We have proposed a concept termed ‘gene-regulating chemoprevention and chemotherapy’ regarding the above pathway. This concept assumes that transcriptional regulation by drugs on tumor-suppressor genes, downstream target genes or functionally similar genes (for example, family genes) of the tumor-suppressor genes would contribute to the prevention of human malignancies. Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differentiation and apoptotic cell death. Previously, we demonstrated that HDAC inhibitors, such as sodium butyrate and trichostatin A (TSA), transcriptionally induce the cyclin-dependent kinase inhibitor p21WAF1/Cip1, a downstream target gene of p53, in a p53-independent manner. Furthermore, we have recently shown that HDAC inhibitors activate Gadd45, another downstream target gene of p53, and p19INK4d, a gene functionally similar to p16INK4a. Our results, taken together with previous findings, suggest that HDAC inhibitors may be one of the most attractive and promising agents for ‘gene-regulating chemoprevention’ and ‘molecular-targeting prevention’ of cancer.
Prevention
;
Malignant Neoplasms
;
Chemoprevention
;
inhibitors
;
Genes
2.A Pharmacoepidemiologic Study on the Relationship between Neuropsychiatric Symptoms and Therapeutic Drugs after Influenza Infection
Toshiharu Fujita ; Yosuke Fujii ; Yoshihiro Watanabe ; Hitoshi Osaka ; Takahito Wada ; Masaaki Mori ; Shumpei Yokota
Japanese Journal of Pharmacoepidemiology 2010;15(2):73-95
Objective: The mechanism underlying the development of neuropsychiatric symptoms such as unconsciousness, abnormal behavior, delirium, hallucinations, and convulsions in influenza has not been thoroughly investigated. The relationship between drug administration and neuropsychiatric symptoms during influenza is also poorly understood. This study is the first pharmacoepidemiologic study focused on investigating the relationship between drug administration and neuropsychiatric symptoms.
Design: Cohort study
Methods: Study subjects were patients under 18 years old who had influenza during the 2006/07 season. We prepared two kinds of questionnaires for doctor and for patient's family, and carried out the survey between January and March, 2007. Using data from 9,389 patients, we analyzed the relationship between neuropsychiatric symptoms, such as delirium, unconsciousness and convulsion, and drug administration of acetaminophen and oseltamivir.
Results: Analysis of the relationship between delirium and drug administration provided hazard ratios of 1.55(p=0.061)for acetaminophen and 1.51(p=0.084)for oseltamivir. These hazard ratios, which were adjusted for risk factors by multivariate analysis of the proportional hazard model, showed an increasing tendency of delirium after administration of each drug. In patients who received oseltamivir, a high incidence of delirium was observed between 6 and 12 hours after onset of fever. Furthermore, delirium was found to develop in a shorter time following oseltamivir use than it did after acetaminophen use. There was no relationship between unconsciousness and acetaminophen administration, as demonstrated by a hazard ratio of 1.06(p=0.839). The incidence of unconsciousness increased significantly with oseltamivir use with a hazard ratio of 1.79(p=0.0389), and unconsciousness was found to occur in a short time after oseltamivir use.
Conclusion: The results obtained from this study suggest that there are increased risks of delirium and unconsciousness with drug administration. Further pharmacoepidemiologic studies for hypothesis testing are required to study the relationship between abnormal behavior and drug administration.
3.Health conditions and life-working style of oyster farmers in Hiroshima Bay.
Seiryo TAKASHINA ; Yoshitaka SEKIGUCHI ; Toyofumi MITSUYAMA ; Hidetaka SENOO ; Yukihiko GOMYO ; Kazuhiko HATTA ; Yoshihiro YOKOTA ; Yasuhiro YOKOSAKI ; Masao DOI
Journal of the Japanese Association of Rural Medicine 1985;34(1):21-33
An investigation was made into the health conditions of oyster farmers in Hiroshima Bay with reference to their job requirements and way of life. The findings are as follows:
Their working conditions are harsh. However, compared with those engaged in agriculture, the oyster farmers eat fairly large amounts of calorific foods, especially animal products. Their alcoholic consumption is also large. They get enough sleep and rest on a regular basis.
Mild obesity, hypertension and hyperlipidemia are prevalent among men, and tendency of obesity is more common among women. Furthermore, those with the risk factors for arteriosclerosis account for more than 50% of the people examined.
From these findings, it could be said that their health is at risk. Appropriate and effective measures should be taken promptly so as to reduce the risks, particularly those risks associated with arteriosclerotic damage. Mechanization will be one of the measures against the health resks that oyster famers are now exposed to. Without preventive measures, there might be an outbreak of the diseases originating in the blood vessels.
4.Glyceraldehyde-Derived Advanced Glycation End Products Accumulate Faster Than N(ε)-(Carboxymethyl) Lysine.
Mami YOKOTA ; Marie SEKITA ; Yuri OKANO ; Hitoshi MASAKI ; Masayoshi TAKEUCHI ; Yoshihiro TOKUDOME
Annals of Dermatology 2017;29(4):508-511
No abstract available.
Glycosylation End Products, Advanced*
;
Lysine*
5.Histone deacetylase inhibitors -Promising agents for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer-.
Youichirou MATSUZAKI ; Yoshihiro SOWA ; Tohru HIROSE ; Tomoya YOKOTA ; Toshiyuki SAKAI
Environmental Health and Preventive Medicine 2003;8(5):157-160
One of the best approaches against cancer is prevention. Inactivation of the p53 or p16(INK4a) genes has been extensively reported in most human cancer cells. Both p53 and p16(INK4a) function as tumor suppressors. Therefore, functional restoration of these molecules is considered to be one of the most useful methods for cancer prevention and therapy. We have proposed a concept termed 'gene-regulating chemoprevention and chemotherapy' regarding the above pathway. This concept assumes that transcriptional regulation by drugs on tumor-suppressor genes, downstream target genes or functionally similar genes (for example, family genes) of the tumor-suppressor genes would contribute to the prevention of human malignancies. Histone deacetylase (HDAC) inhibitors have been shown to be potent inducers of growth arrest, differentiation and apoptotic cell death. Previously, we demonstrated that HDAC inhibitors, such as sodium butyrate and trichostatin A (TSA), transcriptionally induce the cyclin-dependent kinase inhibitor p21(WAF1/Cip1), a downstream target gene of p53, in a p53-independent manner. Furthermore, we have recently shown that HDAC inhibitors activate Gadd45, another downstream target gene of p53, and p19(INK4d), a gene functionally similar to p16(INK4a). Our results, taken together with previous findings, suggest that HDAC inhibitors may be one of the most attractive and promising agents for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer.